Identification of the Major Degradation Pathways of Selumetinib.
Bouchema TSE, Annereau M, Vieillard V, Boquet R, Coelho GA, Castelli F, Solgadi A, Paul M, Yagoubi N, Secretan PH, Do B.
Bouchema TSE, et al. Among authors: secretan ph.
Pharmaceutics. 2022 Nov 30;14(12):2651. doi: 10.3390/pharmaceutics14122651.
Pharmaceutics. 2022.
PMID: 36559146
Free PMC article.